Press release
Global Pancreatic Cancer Market is Projected to Surpass USD 7114.4 Million By the End of 2030 with a Growing CAGR of 12.5% | Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1196
Market Insights: Forecasts and Growth Projections
The global pancreatic cancer market, valued at USD 2448.9 million in 2022, is projected to surge to USD 7114.4 million by 2030, exhibiting a robust Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period from 2023 to 2030.
Pancreatic cancer, a severe and often fatal condition, originates in the pancreas-an abdominal organ situated behind the stomach. Its symptoms often remain unnoticed until the disease reaches advanced stages. Surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy are among the available treatments. The market growth is propelled by the surge in pancreatic cancer cases globally and government initiatives aimed at enhancing healthcare infrastructure.
Driving Factors and Market Dynamics
The upsurge in pancreatic cancer incidence worldwide, largely linked to factors such as rising diabetes rates, obesity, and exposure to toxins, is a pivotal driver for market growth. The disease ranks among the leading causes of cancer-related deaths in various countries. Consequently, the demand for advanced diagnostic tools, effective treatment options, and supportive care services is witnessing a notable uptick. Technological advancements in diagnostics, including imaging techniques and biomarker testing, contribute to early and precise detection, thus improving patient outcomes. However, the high costs associated with treatments and their side effects pose challenges, potentially impeding market growth.
Regional Dynamics and Market Dominance
North America is poised to lead the pancreatic cancer market during the forecast period. The region's growth is underpinned by advanced medical facilities, innovative diagnostics, established competitors, and the rising prevalence of the ailment. Meanwhile, the Asia Pacific region exhibits significant potential for market expansion, driven by improving healthcare infrastructure and rising awareness.
Segments Covered
The report segments the global pancreatic cancer market based on type, treatment, diagnosis, route of administration, end-user, and distribution channel. These encompass exocrine and endocrine types, treatment modalities like chemotherapy, targeted therapy, immunotherapy, and more, various diagnosis methods, diverse administration routes, end-user categories including hospitals, specialty clinics, and homecare, as well as distribution channels such as hospital pharmacies, retail pharmacies, and online platforms.
Companies Profiled
The report offers comprehensive profiles of key industry players, including Bayer AG, Mylan (now part of Viatris), Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GSK plc, Novartis AG, Zydus Lifesciences Ltd., AstraZeneca, and Johnson & Johnson Services, Inc.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/1196
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Pancreatic Cancer Market Highlights
2.2. Pancreatic Cancer Market Projection
2.3. Pancreatic Cancer Market Regional Highlights
Chapter 3. Global Pancreatic Cancer Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Type
3.4.2. IGR-Growth Matrix Analysis by Treatment Type
3.4.3. IGR-Growth Matrix Analysis by Diagnosis
3.4.4. IGR-Growth Matrix Analysis by Route of Administration
3.4.5. IGR-Growth Matrix Analysis by End User
3.4.6. IGR-Growth Matrix Analysis by Distribution Channel
3.4.7. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Pancreatic Cancer Market
Chapter 4. Pancreatic Cancer Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Pancreatic Cancer Market
5.2. Companies Profiles
5.2.1. Bayer AG
5.2.2. Mylan (is now part of Viatris)
5.2.3. Teva Pharmaceutical Industries Ltd.
5.2.4. Sanofi
5.2.5. Pfizer Inc.
5.2.6. GSK plc
5.2.7. Novartis AG
5.2.8. Zydus Lifesciences Ltd.
5.2.9. AstraZeneca
5.2.10. Johnson & Johnson Services, Inc.
Chapter 6. Global Pancreatic Cancer Market by Type
6.1. Exocrine
6.2. Endocrine
Chapter 7. Global Pancreatic Cancer Market by Treatment Type
7.1. Chemotherapy
7.2. Targeted Therapy
7.3. Immunotherapy
7.4. Hormone Therapy
7.5. Others
Chapter 8. Global Pancreatic Cancer Market by Diagnosis
8.1. Blood Test
8.2. Biopsy
8.3. Imaging Tests
8.4. Ultrasound
8.5. Computerized Tomography (CT) scans
8.6. Others
Chapter 9. Global Pancreatic Cancer Market by Route of Administration
9.1. Oral
9.2. Parenteral
9.3. Others
Chapter 10. Global Pancreatic Cancer Market by End User
10.1. Hospitals
10.2. Specialty Clinics
10.3. Homecare
10.4. Others
Chapter 11. Global Pancreatic Cancer Market by Distribution Channel
11.1. Hospital Pharmacy
11.2. Retail Pharmacy
11.3. Online Pharmacy
11.4. Others
Chapter 12. Global Pancreatic Cancer Market by Region 2023-2030
12.1. North America
12.1.1. North America Pancreatic Cancer Market by Type
12.1.2. North America Pancreatic Cancer Market by Treatment Type
12.1.3. North America Pancreatic Cancer Market by Diagnosis
12.1.4. North America Pancreatic Cancer Market by Route of Administration
12.1.5. North America Pancreatic Cancer Market by End User
12.1.6. North America Pancreatic Cancer Market by Distribution Channel
12.1.7. North America Pancreatic Cancer Market by Country
12.1.7.1. The U.S. Pancreatic Cancer Market
12.1.7.1.1. The U.S. Pancreatic Cancer Market by Type
12.1.7.1.2. The U.S. Pancreatic Cancer Market by Treatment Type
12.1.7.1.3. The U.S. Pancreatic Cancer Market by Diagnosis
12.1.7.1.4. The U.S. Pancreatic Cancer Market by Route of Administration
12.1.7.1.5. The U.S. Pancreatic Cancer Market by End User
12.1.7.1.6. The U.S. Pancreatic Cancer Market by Distribution Channel
12.1.7.2. Canada Pancreatic Cancer Market
12.1.7.2.1. Canada Pancreatic Cancer Market by Type
12.1.7.2.2. Canada Pancreatic Cancer Market by Treatment Type
12.1.7.2.3. Canada Pancreatic Cancer Market by Diagnosis
12.1.7.2.4. Canada Pancreatic Cancer Market by Route of Administration
12.1.7.2.5. Canada Pancreatic Cancer Market by End User
12.1.7.2.6. Canada Pancreatic Cancer Market by Distribution Channel
12.1.7.3. Mexico Pancreatic Cancer Market
12.1.7.3.1. Mexico Pancreatic Cancer Market by Type
12.1.7.3.2. Mexico Pancreatic Cancer Market by Treatment Type
12.1.7.3.3. Mexico Pancreatic Cancer Market by Diagnosis
12.1.7.3.4. Mexico Pancreatic Cancer Market by Route of Administration
12.1.7.3.5. Mexico Pancreatic Cancer Market by End User
12.1.7.3.6. Mexico Pancreatic Cancer Market by Distribution Channel
12.2. Europe
12.2.1. Europe Pancreatic Cancer Market by Type
12.2.2. Europe Pancreatic Cancer Market by Treatment Type
12.2.3. Europe Pancreatic Cancer Market by Diagnosis
12.2.4. Europe Pancreatic Cancer Market by Route of Administration
12.2.5. Europe Pancreatic Cancer Market by End User
12.2.6. Europe Pancreatic Cancer Market by Distribution Channel
12.2.7. Europe Pancreatic Cancer Market by Country
12.2.7.1. Germany Pancreatic Cancer Market
12.2.7.1.1. Germany Pancreatic Cancer Market by Type
12.2.7.1.2. Germany Pancreatic Cancer Market by Treatment Type
12.2.7.1.3. Germany Pancreatic Cancer Market by Diagnosis
12.2.7.1.4. Germany Pancreatic Cancer Market by Route of Administration
12.2.7.1.5. Germany Pancreatic Cancer Market by End User
12.2.7.1.6. Germany Pancreatic Cancer Market by Distribution Channel
12.2.7.2. United Kingdom Pancreatic Cancer Market
12.2.7.2.1. United Kingdom Pancreatic Cancer Market by Type
12.2.7.2.2. United Kingdom Pancreatic Cancer Market by Treatment Type
12.2.7.2.3. United Kingdom Pancreatic Cancer Market by Diagnosis
12.2.7.2.4. United Kingdom Pancreatic Cancer Market by Route of Administration
12.2.7.2.5. United Kingdom Pancreatic Cancer Market by End User
12.2.7.2.6. United Kingdom Pancreatic Cancer Market by Distribution Channel
12.2.7.3. France Pancreatic Cancer Market
12.2.7.3.1. France Pancreatic Cancer Market by Type
12.2.7.3.2. France Pancreatic Cancer Market by Treatment Type
12.2.7.3.3. France Pancreatic Cancer Market by Diagnosis
12.2.7.3.4. France Pancreatic Cancer Market by Route of Administration
12.2.7.3.5. France Pancreatic Cancer Market by End User
12.2.7.3.6. France Pancreatic Cancer Market by Distribution Channel
12.2.7.4. Italy Pancreatic Cancer Market
12.2.7.4.1. Italy Pancreatic Cancer Market by Type
12.2.7.4.2. Italy Pancreatic Cancer Market by Treatment Type
12.2.7.4.3. Italy Pancreatic Cancer Market by Diagnosis
12.2.7.4.4. Italy Pancreatic Cancer Market by Route of Administration
12.2.7.4.5. Italy Pancreatic Cancer Market by End User
12.2.7.4.6. Italy Pancreatic Cancer Market by Distribution Channel
12.2.7.5. Rest of Europe Pancreatic Cancer Market
12.2.7.5.1. Rest of Europe Pancreatic Cancer Market by Type
12.2.7.5.2. Rest of Europe Pancreatic Cancer Market by Treatment Type
12.2.7.5.3. Rest of Europe Pancreatic Cancer Market by Diagnosis
12.2.7.5.4. Rest of Europe Pancreatic Cancer Market by Route of Administration
12.2.7.5.5. Rest of Europe Pancreatic Cancer Market by End User
12.2.7.5.6. Rest of Europe Pancreatic Cancer Market by Distribution Channel
12.3. Asia Pacific
12.3.1. Asia Pacific Pancreatic Cancer Market by Type
12.3.2. Asia Pacific Pancreatic Cancer Market by Treatment Type
12.3.3. Asia Pacific Pancreatic Cancer Market by Diagnosis
12.3.4. Asia Pacific Pancreatic Cancer Market by Route of Administration
12.3.5. Asia Pacific Pancreatic Cancer Market by End User
12.3.6. Asia Pacific Pancreatic Cancer Market by Distribution Channel
12.3.7. Asia Pacific Pancreatic Cancer Market by Country
12.3.7.1. China Pancreatic Cancer Market
12.3.7.1.1. China Pancreatic Cancer Market by Type
12.3.7.1.2. China Pancreatic Cancer Market by Treatment Type
12.3.7.1.3. China Pancreatic Cancer Market by Diagnosis
12.3.7.1.4. China Pancreatic Cancer Market by Route of Administration
12.3.7.1.5. China Pancreatic Cancer Market by End User
12.3.7.1.6. China Pancreatic Cancer Market by Distribution Channel
12.3.7.2. Japan Pancreatic Cancer Market
12.3.7.2.1. Japan Pancreatic Cancer Market by Type
12.3.7.2.2. Japan Pancreatic Cancer Market by Treatment Type
12.3.7.2.3. Japan Pancreatic Cancer Market by Diagnosis
12.3.7.2.4. Japan Pancreatic Cancer Market by Route of Administration
12.3.7.2.5. Japan Pancreatic Cancer Market by End User
12.3.7.2.6. Japan Pancreatic Cancer Market by Distribution Channel
12.3.7.3. India Pancreatic Cancer Market
12.3.7.3.1. India Pancreatic Cancer Market by Type
12.3.7.3.2. India Pancreatic Cancer Market by Treatment Type
12.3.7.3.3. India Pancreatic Cancer Market by Diagnosis
12.3.7.3.4. India Pancreatic Cancer Market by Route of Administration
12.3.7.3.5. India Pancreatic Cancer Market by End User
12.3.7.3.6. India Pancreatic Cancer Market by Distribution Channel
12.3.7.4. South Korea Pancreatic Cancer Market
12.3.7.4.1. South Korea Pancreatic Cancer Market by Type
12.3.7.4.2. South Korea Pancreatic Cancer Market by Treatment Type
12.3.7.4.3. South Korea Pancreatic Cancer Market by Diagnosis
12.3.7.4.4. South Korea Pancreatic Cancer Market by Route of Administration
12.3.7.4.5. South Korea Pancreatic Cancer Market by End User
12.3.7.4.6. South Korea Pancreatic Cancer Market by Distribution Channel
12.3.7.5. Australia Pancreatic Cancer Market
12.3.7.5.1. Australia Pancreatic Cancer Market by Type
12.3.7.5.2. Australia Pancreatic Cancer Market by Treatment Type
12.3.7.5.3. Australia Pancreatic Cancer Market by Diagnosis
12.3.7.5.4. Australia Pancreatic Cancer Market by Route of Administration
12.3.7.5.5. Australia Pancreatic Cancer Market by End User
12.3.7.5.6. Australia Pancreatic Cancer Market by Distribution Channel
12.3.7.6. Rest of Asia-Pacific Pancreatic Cancer Market
12.3.7.6.1. Rest of Asia-Pacific Pancreatic Cancer Market by Type
12.3.7.6.2. Rest of Asia-Pacific Pancreatic Cancer Market by Treatment Type
12.3.7.6.3. Rest of Asia-Pacific Pancreatic Cancer Market by Diagnosis
12.3.7.6.4. Rest of Asia-Pacific Pancreatic Cancer Market by Route of Administration
12.3.7.6.5. Rest of Asia-Pacific Pancreatic Cancer Market by End User
12.3.7.6.6. Rest of Asia-Pacific Pancreatic Cancer Market by Distribution Channel
12.4. RoW
12.4.1. RoW Pancreatic Cancer Market by Type
12.4.2. RoW Pancreatic Cancer Market by Treatment Type
12.4.3. RoW Pancreatic Cancer Market by Diagnosis
12.4.4. RoW Pancreatic Cancer Market by Route of Administration
12.4.5. RoW Pancreatic Cancer Market by End User
12.4.6. RoW Pancreatic Cancer Market by Distribution Channel
12.4.7. RoW Pancreatic Cancer Market by Sub-region
12.4.7.1. Latin America Pancreatic Cancer Market
12.4.7.1.1. Latin America Pancreatic Cancer Market by Type
12.4.7.1.2. Latin America Pancreatic Cancer Market by Treatment Type
12.4.7.1.3. Latin America Pancreatic Cancer Market by Diagnosis
12.4.7.1.4. Latin America Pancreatic Cancer Market by Route of Administration
12.4.7.1.5. Latin America Pancreatic Cancer Market by End User
12.4.7.1.6. Latin America Pancreatic Cancer Market by Distribution Channel
12.4.7.2. Middle East Pancreatic Cancer Market
12.4.7.2.1. Middle East Pancreatic Cancer Market by Type
12.4.7.2.2. Middle East Pancreatic Cancer Market by Treatment Type
12.4.7.2.3. Middle East Pancreatic Cancer Market by Diagnosis
12.4.7.2.4. Middle East Pancreatic Cancer Market by Route of Administration
12.4.7.2.5. Middle East Pancreatic Cancer Market by End User
12.4.7.2.6. Middle East Pancreatic Cancer Market by Distribution Channel
12.4.7.3. Africa Pancreatic Cancer Market
12.4.7.3.1. Africa Pancreatic Cancer Market by Type
12.4.7.3.2. Africa Pancreatic Cancer Market by Treatment Type
12.4.7.3.3. Africa Pancreatic Cancer Market by Diagnosis
12.4.7.3.4. Africa Pancreatic Cancer Market by Route of Administration
12.4.7.3.5. Africa Pancreatic Cancer Market by End User
12.4.7.3.6. Africa Pancreatic Cancer Market by Distribution Channel
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/1196
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of Pancreatic Cancer.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pancreatic Cancer Market is Projected to Surpass USD 7114.4 Million By the End of 2030 with a Growing CAGR of 12.5% | Infinium Global Research here
News-ID: 3302441 • Views: …
More Releases from Infinium Global Research LLP
Saudi Arabia Healthcare Cybersecurity Market is Expected to Reach USD 1650 Milli …
The Saudi Arabia healthcare cybersecurity market has entered a phase of accelerated growth, driven by the country's ongoing digital transformation and the rapid adoption of advanced healthcare IT platforms. Valued at USD 540 million in 2023, the market is projected to reach USD 1,650 million by 2032, expanding at a CAGR of 15% during 2024-2032. This growth is fueled by the Kingdom's National e-Health Strategy, rising cyberthreats targeting healthcare systems,…
Global Aviation Fuel Market Outlook 2024-2032: Growth from USD 289.34 Billion to …
The aviation fuel market has expanded steadily in recent years, driven by rising global air traffic, economic improvements, and the rapid expansion of commercial and cargo aviation networks. The market was valued at USD 289.34 billion in 2023 and is projected to reach USD 437.34 billion by 2032, reflecting stable expansion supported by increasing aircraft operations, modernization of fleets, and the growing need for reliable fuel logistics. Key growth drivers…
United States Beauty and Wellness Market is Expected to Reach USD 143.27 Million …
The United States beauty and wellness market continues to evolve rapidly, shaped by shifting consumer priorities, rising disposable incomes, digital-first retail strategies, and the strong influence of self-care culture. With a valuation of USD 97 billion in 2023, the market is firmly positioned as one of the world's largest and most dynamic consumer-driven sectors. Increased awareness of holistic wellbeing, demand for clean beauty solutions, and adoption of premium skincare and…
United States Pharmerging Market is Expected to Reach USD 1172.82 Billion in 203 …
The United States pharmerging market has emerged as one of the fastest-growing components of the broader healthcare and pharmaceutical ecosystem, driven by rapid advancements in drug manufacturing, rising healthcare expenditure, and a surge in lifestyle-related diseases. Valued at USD 540 billion in 2023, the market is projected to reach USD 1172.82 billion by 2032, expanding at a CAGR of 9% during 2024-2032. This growth reflects the country's robust pharmaceutical infrastructure…
More Releases for Pancreatic
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Pancreatic Cancer Diagnostic Industry Market Size Be by 2025?
The sector dedicated to diagnosing pancreatic cancer has experienced significant upward momentum lately, projecting an expansion from a valuation of $4.24 billion in 2024 to $4.54 billion in 2025, reflecting a steady compound annual growth rate of…
Growing Pancreatic Cancer Cases : Pivotal Factor Influencing Pancreatic Cancer D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pancreatic Cancer Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pancreatic cancer drugs has seen consistent growth over the past few years. An escalation from $3.96 billion in 2024 to $4.1 billion in 2025 is projected, marking a compound annual…
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Pancreatic Cancer Diagnostic Market Through 2025?
The market size for pancreatic cancer diagnostics has been witnessing robust growth in recent times. There will be a growth from $4.24 billion in 2024 to $4.55 billion in 2025, showcasing a Compound Annual Growth Rate…
Pancreatic Cancer Diagnostic Market Surges In Response To Escalating Prevalence …
The Pancreatic Cancer Diagnostic Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Pancreatic Cancer Diagnostic Market Size and Projected Growth Rate?
There has been a significant expansion in the pancreatic cancer diagnostic market recently. This market is projected to increase from a value…
Pancreatic Amylase Reagent Kits: Streamlining Enzyme Analysis for Efficient Panc …
Pancreatic Amylase Reagent Kits Market 2023 Forecast: Unveiling Opportunities and Growth
Pancreatic Amylase Reagent Kits Market research report helps to recognize the market challenges and opportunities. Global Pancreatic Amylase Reagent Kits Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of…
Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of…
